Abstract: The present invention provides a pharmaceutical composition for treating multiple sclerosis based on AMPK inhibitory function and zinc homeostasis controlling function that effectively treats multiple sclerosis due to its excellent neuroprotective effect without side effects.
Type:
Grant
Filed:
November 12, 2020
Date of Patent:
July 1, 2025
Assignee:
ZINCURE CORP.
Inventors:
Yang-Hee Kim, Jae Won Eom, Sang Won Suh, Bo Young Choi